Human beta-defensin chimeric peptides
This invention exploits the remarkable differences in the antimicrobial properties shown by human beta-defensins 2 and 3 (HBD2 and HBD3) against Gram-positive and Gram-negative bacteria through the generation of chimeric molecules of HBD2 and HBD3 with improved activity against E.coli and S.aureus strains compared to wild-type. The chimeras are very interesting novel molecules, based on the natural human proteins, which offer a combined and improved defensin activity.
Further Information: PDF
Patent- und Verwertungsagentur für die Wissenschaftlichen Einrichtungen in Schleswig-Holstein GmbH (PVA SH)
Phone: +49 (0)431/8009937
Contact
Dr. Alexandra Baumgartner
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Superradiant atoms could push the boundaries of how precisely time can be measured
Superradiant atoms can help us measure time more precisely than ever. In a new study, researchers from the University of Copenhagen present a new method for measuring the time interval,…
Ion thermoelectric conversion devices for near room temperature
The electrode sheet of the thermoelectric device consists of ionic hydrogel, which is sandwiched between the electrodes to form, and the Prussian blue on the electrode undergoes a redox reaction…
Zap Energy achieves 37-million-degree temperatures in a compact device
New publication reports record electron temperatures for a small-scale, sheared-flow-stabilized Z-pinch fusion device. In the nine decades since humans first produced fusion reactions, only a few fusion technologies have demonstrated…